-+ 0.00%
-+ 0.00%
-+ 0.00%

Elevara Medicines appoints IO Biotech founder Mai-Britt Zocca as CEO

PUBT·07/14/2026 19:35:51
Listen to the news
Elevara Medicines appoints IO Biotech founder Mai-Britt Zocca as CEO
  • Elevara Medicines appointed IO Biotech founder Mai-Britt Zocca as CEO, effective July 1, replacing founder Emma Tinsley.
  • Tinsley moved to a non-executive director role on Elevara’s board.
  • Elevara raised USD 70 million Series A in October 2025 led by Forbion, Sofinnova Partners; included Monograph Capital, Weatherden.
  • Phase 2b START-SYNERGY trial for ELV001 began March 2026; 180 rheumatoid arthritis patients; primary endpoint DAS28-CRP change at week 12.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Forbion Capital Partners Management Services BV published the original content used to generate this news brief on July 14, 2026, and is solely responsible for the information contained therein.